T2 Biosystems Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Sep 24 | Sell€120 | David Elsbree | Individual | 55 | €2.18 |
Insider Trading Volume
Insider Buying: 3T2 insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 1,211 | 0.00589% |
Individual Insiders | 1,021,160 | 4.97% |
Hedge Funds | 1,396,000 | 6.79% |
Institutions | 1,510,712 | 7.35% |
General Public | 5,955,908 | 29% |
VC/PE Firms | 10,677,973 | 51.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 407.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,677,973 | €5.1m | 0% | 100.0% | |||
1,396,000 | €668.2k | -15.8% | 0.02% | |||
1,000,000 | €478.6k | 0% | no data | |||
755,000 | €361.4k | 0% | 50.57% | |||
390,368 | €186.8k | 24.8% | no data | |||
90,880 | €43.5k | -30.3% | no data | |||
76,827 | €36.8k | -1.88% | no data | |||
63,743 | €30.5k | 0% | no data | |||
45,481 | €21.8k | 9.16% | no data | |||
39,140 | €18.7k | 0% | no data | |||
27,142 | €13.0k | -30.2% | no data | |||
20,000 | €9.6k | 0% | no data | |||
14,750 | €7.1k | 0.31% | no data | |||
4,001 | €1.9k | 40.1% | no data | |||
2,399 | €1.1k | -68.7% | no data | |||
1,211 | €579.7 | 0% | no data | |||
400 | €191.9 | 0% | no data | |||
310 | €148.6 | 0% | no data | |||
289 | €138.8 | -71.4% | no data | |||
200 | €95.5 | 0% | no data | |||
141 | €67.9 | 0% | no data | |||
135 | €65.0 | 0% | no data | |||
101 | €48.2 | 0% | no data | |||
85 | €40.4 | 0% | no data | |||
77 | €36.4 | 0% | no data |